早期中轴型脊柱关节炎长期抗TNF治疗中骶髂关节结构损伤进展:依那西普持续治疗六年结果
该研究基于ESTHER试验,评估早期中轴型脊柱关节炎患者接受依那西普最长6年治疗期间骶髂关节放射学进展。42例有可用影像的患者中,骶髂关节炎总和评分在各时间 interval 平均变化接近零,提示长期抗TNF治疗减缓结构损伤进展;基线CRP升高和MRI骶髂关节骨炎评分与进展独立相关。
要点
- 长期依那西普治疗下骶髂关节放射学评分变化接近零,提示结构损伤进展减缓。
- 基线CRP升高与MRI骶髂关节骨炎评分独立预测骶髂关节炎放射学进展。
- 早期中轴型SpA患者长期抗TNF治疗中仍需关注炎症标志物和MRI骨炎。
核心结论
- 长期抗TNF治疗减缓早期中轴型脊柱关节炎患者骶髂关节结构损伤进展。
- 基线CRP升高和MRI骶髂关节骨炎与放射学骶髂关节炎进展独立相关。
研究设计与样本
- 基于ESTHER试验,选择接受依那西普治疗最长6年的早期中轴型SpA患者。
- 42例有基线及至少1个随访时间点(第2、4或6年)骶髂关节X线片的患者纳入分析。
- 两名对临床数据设盲的读者按改良纽约标准(每侧骶髂关节0-4分)评分,取均值计算骶髂关节炎总和评分(0-8分)。
- 基线、第2年和第4年MRI按Berlin MRI评分系统评估骶髂关节活动性和慢性炎症改变。
主要发现
- 骶髂关节炎总和评分平均变化:基线至第2年0.13±0.73,第2至4年-0.27±0.76,第4至6年-0.09±0.68。
- 纵向混合模型分析中,CRP升高(β=0.58 [95%CI 0.24, 0.91])与骶髂关节炎总和评分进展独立相关。
- MRI骶髂关节骨炎评分(β=0.06 [95%CI 0.03, 0.10])与骶髂关节炎总和评分进展独立相关。
关键数值与推荐
- 骶髂关节X线按改良纽约标准评分,每侧0-4分,总和评分范围0-8分。
- MRI按Berlin MRI评分系统评估活动性和慢性炎症改变。
- CRP升高与进展独立相关(β=0.58 [95%CI 0.24, 0.91])。
- MRI骶髂关节骨炎评分与进展独立相关(β=0.06 [95%CI 0.03, 0.10])。
临床怎么用
- 对早期中轴型SpA患者长期抗TNF治疗时,可关注基线CRP和MRI骶髂关节骨炎以评估结构进展风险。
- 长期抗TNF治疗下骶髂关节放射学进展总体缓慢,但仍需监测炎症指标和影像学变化。
局限性
- 仅42例患者有可用X线片,样本量有限。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate radiographic progression in the sacroiliac (SI) joints and to identify its predictors during long-term treatment (up to 6 years) with the tumor necrosis factor (TNF) inhibitor etanercept in patients with early axial spondyloarthritis (SpA). METHODS: Patients with early axial SpA who were treated with etanercept for up to 6 years in the Etanercept versus Sulfasalazine in Early Axial Spondyloarthritis (ESTHER) trial were selected based on the availability of radiographs of the SI joints. Two readers who were blinded with regard to clinical data scored the radiographs according to the modified New York criteria (range 0-4 per SI joint). A sacroiliitis sum score (total range 0-8) was calculated as the mean of the scores of the 2 readers. Active and chronic inflammatory changes in the SI joints on magnetic resonance imaging (MRI) performed at baseline, year 2, and year 4 were assessed according to the Berlin MRI scoring system. RESULTS: Of the 76 patients originally included in the study, 42 had radiographs of the SI joints available at baseline and at least 1 follow-up time point (year 2, 4, or 6). The mean ± SD change in the sacroiliitis sum score was 0.13 ± 0.73, -0.27 ± 0.76, and -0.09 ± 0.68, in the time intervals baseline to year 2, year 2 to year 4, and year 4 to year 6, respectively. In the longitudinal mixed model analysis, elevated C-reactive protein level (β = 0.58 [95% confidence interval 0.24, 0.91]) and MRI SI joint osteitis score (β = 0.06 [95% confidence interval 0.03, 0.10]) were independently associated with progression of the sacroiliitis sum score. CONCLUSION: Our findings indicate that long-term anti-TNF therapy decelerates the progression of structural damage in the SI joints. Elevated CRP level and presence of osteitis on MRI were independently associated with radiographic sacroiliitis progression.
引用
- Rios Rodriguez V, Hermann KG, Weiß A, et al. Progression of Structural Damage in the Sacroiliac Joints in Patients With Early Axial Spondyloarthritis During Long-Term Anti-Tumor Necrosis Factor Treatment: Six-Year Results of Continuous Treatment With Etanercept. Arthritis Rheumatol. 2019. PMID: 30625261. doi:10.1002/art.40786
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。